Publicacions en col·laboració amb investigadors/es de Erasmus University Rotterdam (26)

2018

  1. Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy

    Leukemia, Vol. 32, Núm. 1, pp. 21-29

  2. Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: Executive summary

    EuroIntervention, Vol. 13, Núm. 13, pp. 1574-1586

  3. Report of an ESC-EAPCI task force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: Executive summary

    European Heart Journal, Vol. 39, Núm. 18, pp. 1591-1601

  4. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

    The Lancet, Vol. 392, Núm. 10151, pp. 940-949

2017

  1. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

    European Heart Journal, Vol. 38, Núm. 42, pp. 3124-3134

2013

  1. Diurnal triglyceridemia in relation to alcohol intake in men

    Nutrients, Vol. 5, Núm. 12, pp. 5114-5126

2001

  1. Continued benefit of coronary stenting versus balloon angioplasty: Five-year clinical follow-up of Benestent-I trial

    Journal of the American College of Cardiology, Vol. 37, Núm. 6, pp. 1598-1603

  2. Electrophysiologic characteristics in initiation of paroxysmal atrial fibrillation from a focal area

    Journal of the American College of Cardiology, Vol. 37, Núm. 6, pp. 1658-1664

  3. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS)

    Circulation, Vol. 104, Núm. 22, pp. 2689-2693

1998

  1. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

    Lancet, Vol. 352, Núm. 9129, pp. 673-681

1996

  1. Heparin-coated Palmaz-Schatz stents in human coronary arteries: Early outcome of the Benestent-II pilot study

    Circulation, Vol. 93, Núm. 3, pp. 412-422

  2. Impact of plaque morphology and composition on the mechanisms of lumen enlargement using intracoronary ultrasound and quantitative angiography after balloon angioplasty

    American Journal of Cardiology, Vol. 77, Núm. 2, pp. 115-121

1995

  1. Can intracoronary ultrasound correctly assess the luminal dimensions of coronary artery lesions? A comparison with quantitative angiography

    European Heart Journal, Vol. 16, Núm. 1, pp. 112-119

  2. Intracoronary two-dimensional ultrasound imaging in the assessment of plaque morphologic features and the planning of coronary interventions

    American Heart Journal, Vol. 129, Núm. 1, pp. 177-187

  3. Ischemia-related lesion characteristics in patients with stable or unstable angina: A study with intracoronary angioscopy and ultrasound

    Circulation, Vol. 92, Núm. 6, pp. 1408-1413

  4. Mechanisms of luminal enlargement and quantification of vessel wall trauma following balloon coronary angioplasty and directional atherectomy: A study using intracoronary ultrasound, angioscopy and angiography

    European Heart Journal, Vol. 16, Núm. 11, pp. 1603-1612

  5. Presence of Thrombosis in Coronary Atherosclerotic Plaques

    European Journal of Cardiovascular Prevention & Rehabilitation, Vol. 2, Núm. 3, pp. 189-196

1994

  1. Angioscopic versus angiographic detection of initial detection of intimal dissection and intracoronary thrombus

    Journal of the American College of Cardiology, Vol. 24, Núm. 3, pp. 649-654

  2. Intracoronary ultrasound and angioscopic imaging facilitating the understanding and treatment of post-infarction angina

    European Heart Journal, Vol. 15, Núm. 7, pp. 997-1001

  3. Prevention of restenosis after coronary balloon angioplasty: Rationale and design of the fluvastatin angioplasty restenosis (FLARE) trial

    The American Journal of Cardiology, Vol. 73, Núm. 14